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The aim of this study is to investigate the role of chaperonin-containing t-complex polypeptide 1 beta (CCT2) in the regulation
of mouse mesangial cell (mMC) contraction, proliferation, and migration with ﬁlamentous/globular-(F/G-) actin ratio under
high glucose induction. A low CCT2mMC model induced by treatment of small interference RNA was established. Groups with
and without low CCT2 induction examined in normal and high (H) glucose conditions revealed the following major results: (1)
low CCT2 or H glucose showed the ability to attenuate F/G-actin ratio; (2) groups with low F/G-actin ratio all showed less cell
contraction; (3) suppression of CCT2 may reduce the proliferation and migration which were originally induced by H glucose. In
conclusion, CCT2 can be used as a speciﬁc regulator for mMC contraction, proliferation, and migration aﬀe ct e db ygl u c o s e ,wh i c h
mechanism may involve the alteration of F-actin, particularly for cell contraction.
1.Introduction
Functions of mesangial cell contraction, migration, and
proliferation have been reported to be correlated with the
development of diabetic nephropathy (DN). Mesangial cell
contraction regulating intraglomerular pressure contributes
to the occurrence of glomerular hyperﬁltration in early
DN and then progresses to end-stage renal disease (ESRD)
[1]. Alteration in mesangial cell migration may limit repair
following mesangiolysis and thereby contribute to the loss
of kidney function in diabetic nephropathy [2, 3]. Aberrant
proliferation of mesangial cells is commonly observed in DN
that can lead to ESRD [4]. As the integrity of cytoskeletons
is changed during mesangial cell contraction, migration, and
proliferation, actin, the most important cytoskeletal protein,
should play a role in the development of DN [5].
Actin is often the most abundant protein in a cell,
comprising up to 15% of total protein. The function of
actin in eukaryotic cells is ubiquitous, including regulation
of cell contraction, adherence, movement, and phagocytosis.
Actin in cells is generally present interchangeably between
a monomer and a polymer, in which globular-(G-) actin
subunits assemble into long ﬁlamentous polymers called
F-actin. Some cellular functions involving cytoskeletons
are regulated by this process of actin polymerization [6].
The chaperonin family may play an important role in
maintaining the normal function of actin as the function
of chaperone-assisted protein folding in cell allows many
cytosolic proteins to attain the correct folded states and
functional conformations during protein synthesis or during
recovery from their denatured states [7].2 Experimental Diabetes Research
The two most abundant classes of molecular chaperones
aretheheatshockprotein(HSP)60andHSP70.HSP60chap-
erones, also termed chaperonins, are found in all organisms,
and are classiﬁed into two distinct types. Type I is discovered
in prokaryotic cells and endosymbiotic organelles. Type II
is found in eukaryotic cytosol and is termed chaperonin-
containing t-complex polypeptide 1 (CCT) [8]. CCT is
composed of 8 diﬀerent subunits (CCTαβγδεζηθ, the
equivalentofCCT1,2,3,4,5,6,7,and8),buttheirfunctions
a r es t i l ln o tw e l lu n d e r s t o o d .
Up to present, available data [9–12] suggests that CCT is
the only chaperonin known to be abundant in the eukaryotic
cytosol [11] and the primary substrate for cytoskeletal
proteins, tubulins, and actins. Therefore, it is of interest
to know how CCT interacts with cytoskeletal proteins and
involvesincellfunctions,suchascontraction,migration,and
proliferation.
Of all CCT subunits, CCT2 has been proven to correlate
with the function of actin [9]. Furthermore, CCT2 is sug-
gested to have a relationship with mesangial cell contraction
in our own proteomic study [13]. Therefore, in order to
investigatetheeﬀectofCCT2onthecytoskeletalfunctionsof
mesangial cells, an in vitro cell model capable of attenuating
CCT2 expression by small interfering RNA (siRNA) was
established. The aim of this study is to investigate if a
relationship exists between CCT2 and F/G actin on various
cell functions, including contraction, migration, and prolif-
eration.
2.MaterialsandMethods
2.1. siRNA Transfection and Experimental Protocol. As our
previous study found mouse mesangial cells (mMCs) incu-
bating with high glucose has the upregulation of CCT2,
the prime work of this study is to ﬁnd the optimal
amount of siRNA to establish a low CCT2 model. In brief,
mycoplasma-free SV 40-transformed mMCs were prepared
and kept as described previously [13, 14]. These mMCs
(1× 105/well) were maintained in DMEM+F12 containing
5% FBS and 21.25mM D-glucose in 6-well plates. Once
the cells were subconﬂuent, the medium was changed to
Transfection Medium (Santa Cruz, sc-36868, USA), Trans-
fection Reagent (TR, Santa Cruz, sc-29528, USA), and CCT2
siRNA suspension (Santa Cruz, sc-36625, USA), according
to manufacturer’s instructions. The volume of TR was ﬁxed
at 6ul per the instructions. The optimal siRNA amount was
determined by mMCs transfecting with the diﬀerent volume
of CCT2 siRNA 2, 4, and 6ul per well. After 12hrs, the whole
medium was changed to 21.25mM glucose with 1% fetal
bovine serum (FBS) for 24hrs. Cells from these diﬀerent
mixeswereharvestedforproteinextraction.Westernblotting
was used to analyze the expression of CCT 2. Optimal ratio
between the volume of TR and siRNA (TR-to-siRNA) was
established.
Once the optimal ratio of TR-to-siRNA was determined,
the subsequent experiments were as follows. First, mesangial
cells were treated with TR containing CCT2 siRNA, scramble
siRNA (CsiRNA, Santa Cruz, sc-37007, USA), and TR only.
After 12hrs, the concentration of culture medium among
the above three groups was changed into 6.6mM (N) and
21.25mM (H) D-glucose for another 24hrs. To validate the
sequence speciﬁcity of gene knockdown in vitro, six groups,
TR pN, CsiRNA pN, CCT2siRNA pN, TR pH, CsiRNA
pH, and CCT2siRNA pH, were designed for the subsequent
experimentsassayingtheproteinexpressionofCCT2andcell
viability. Due to similar results in groups TR pN and CsiRNA
pN, groups CsiRNA pN, CCT2siRNA pN, CsiRNA pH,
and CCT2siRNA pH were selected for further experiments
concerning the F/G-actin ratio, the arrangement of F-actin,
and cell contraction, migration, and proliferation.
2.2. Cell Viability. To test the cell viability, MTT assay was
used. Six groups weredesigned asdescribed above. The MTT
method was followed as previously described [14].
2.3.WesternBlot(WB)fortheAmountofCCT2andF/G-Actin
Ratio. To determine F/G-actin ratio and CCT2, mMCs were
cultured in 10cm Petri dishes at a density of 1 × 106cells per
well for protein extraction.
For CCT2, in brief, the cells were washed with ice-cold
PBS and lysed in situ with 0.5mL ice-cold lysis buﬀer (2M
thiourea, 7M urea, 4% CHAPS, and 0.5% ampholyte) at
4◦C for 15mins. For whole-cell preparations, supernatants
were collected after centrifugation at 13000rpm for 20mins.
Protein concentration was determined using the Bio-Rad
protein assay kit (Bio-Rad Hercules, CA, USA). Samples
were stored at −70◦C until use. The protocol for WB was
similar to the method previously described. The membranes
were incubated overnight at 4◦C with antibodies against
CCT2 (Santa Cruz, CA, USA) in a ratio of 1:500 in TBST
containing 1% BSA. Horseradish Peroxidase-(HRP-) labeled
secondary antibody (Jackson ImmunoResearch, PA, USA)
was used to detect CCT2 proteins.
For the F/G-actin ratio, protein extracts from mMCs
were subjected to an F/G-actin in vivo assay kit (Cytoskele-
ton, CO, USA) based on the manufacturer’s protocol. Brieﬂy,
cells were lysed with a cell lysis and F-actin stabilization
buﬀer and homogenized using 26G syringes. Cell lysates
were centrifuged at 100000g for 60min at 37◦C. Then
supernatants (G-actin) were separated from the pellets (F-
actin) and were immediately placed on ice. Pellets were
resuspended to the same volume as the supernatants using
ice-cold ddH2O containing 1% cytochalasin D and were
incubated on ice for 60mins. Equal amounts of the samples
(supernatant and pellet) were loaded into each lane and
analyzed by WB with 1:500 dilution of antiactin antibody
(Cytoskeleton, CO, USA) incubated in a blocking buﬀer for
1hr at room temperature (RT). Blots were washed three
times, and then the membranes were incubated in a 1:10000
dilution of goat anti-rabbit HRP (Jackson Immunoresearch,
PA, USA) in TBST for 30mins at RT. Membranes were
washed three times, and the membrane-bound antibody
detected was incubated with WB luminol reagent kit (Santa
Cruz biotechnology, CA, USA) and captured on X-ray ﬁlm.
2.4. Immunoﬂuorescence for the Localization of F-Actin. Im-
munoﬂuorescence (IF) staining of F-actin for cells indicated
a cytoskeletal rearrangement in the cells [15, 16]. To localizeExperimental Diabetes Research 3
the expression of F-actin, mMCs were subjected to IF. mMCs
were plated on 22mm glass coverslips, washed with PBS,
and then ﬁxed with 3.7% paraformaldehyde for 10min at
RT. Cells were then permeabilized with PBS + 0.1% Triton
X-100 for 5min at RT, blocked with PBS + 0.1% BSA for
20min at RT, then thoroughly rinsed with PBS and stained
with Phallacidin conjugate with the green ﬂuorescent Alexa
Fluor 488 (Molecular Probes Inc., Cat. No. A12379, Ore,
USA). A 1:500 dilution in blocking buﬀer 10mins was
used to label the F-actin. After incubating with phallacidin,
the cells were treated with 4 ,6-diamidino-2-phenylindole
(DAPI, Molecular Probes Inc., Cat. No. D1306, Ore, USA)-
dilactate 2mins to label the nuclei. The developed sections
werevisualizedusinganopticalphotomicroscope(Olympus,
Tokyo, Japan). Negative controls, from which primary
antibodies were omitted, were included in the assay.
2.5. Cell Contraction. Phorbol 12-myristate 13-acetate
(PMA, Merck Chemicals Darmstadt, Germany) was used to
induce mMC contraction, which was assessed from changes
in the planar surface area as described previously [14].
mMCs were cultured in 24-well plates at a density of 1 × 103
cells per well. Cells from study groups for cell contraction
were assayed and analyzed. For detecting the role of F-actin,
the F/G-actin ratio and the arrangement of F-actin in mMC
before and after PMA stimulation were evaluated by WB and
IF, respectively.
2.6. Cell Migration. F o rc e l lm i g r a t i o n ,m M C sw e r ec u l t u r e d
in a 6-well plate at a density of 1 × 106cells per well.
mMCs from study groups were applied to the assay of cell
migration as previously described [17]. At the time point
of 0hr, a single wound was created in the center of the cell
monolayer by gentle removal of the attached cells with a
sterile plastic pipette tip. The debris was removed by washing
with serum-free medium. Subsequently, at the time point
of 12hr, the wound was observed; the cells which migrated
into the wounded area or protruded from the border of the
wound were visualized and photographed under an inverted
microscope. Each experiment was performed at least three
times independently. For analysis, an Image J ﬁle was opened
at 0 and 12hr and the rate of wound closure was calculated.
Data are expressed as percentage wound closure relative to
the width of control wounds photographed at 0hr. The
wound closure area of the cells cultured in normal glucose
was set at 100% [18]. In addition, mMCs at 0hr and 12hr
were harvested for determining the F/G-actin ratio and the
arrangement of F-actin.
2.7.CellProliferation. Fortheevaluationofcellproliferation,
mMCs were cultured in a 96-well plate at a density of 1 ×
103cells per well. The study groups were applied to the
assay of cell proliferation using MTT assay. The protocol
for MTT was performed as previously described [14].
According to our experimental design, cells from study
groups were checked with MTT at the time points 0 and
12hr. At 0hr, MTT data was analyzed, so the eﬀect of
CCT2siRNAonmesangialcellproliferationwasdetermined.
Further, the growth rate of mesangial cell from 0 to 12hr
was calculated. The formula for the growth rate is 12hr–
0hr/0hr. Each experiment was performed at least three
times independently. In addition, mMCs at 0 and 12hr
were harvested for determining the F/G-actin ratio and the
arrangement of F-actin.
2.8. Statistical Analysis. All experiments were repeated at
least three times. Results within groups are expressed as
the mean ± SEM. Unpaired t-tests were used to assess the
statistical signiﬁcance of diﬀerences between two groups,
and paired t-tests were used for within-group comparisons.
ANOVA with Tukey’s multiple comparison test was used for
comparisons between more than two groups. A P value of
less than 0.05 was considered signiﬁcant.
3. Results
3.1. Optimal Ratio of TR-to-siRNA for Establishing a Low
CCT2 Cell Model. As seen in Figures 1(a) and 1(b),g r o u p s
6:2, 6:4, and 6:6, all with diﬀerent volume, showed the
attenuating eﬀect on the expression of CCT2 in mMCs when
compared to group TR pN. The group with the ratio of 6:2
showed the most signiﬁcant eﬀect over the other groups,
yielding around 50% reduction of CCT2 level. We suggest
thattheidealratioofTR-to-siRNAis6:2forblockingCCT2.
A low CCT2 cell model is thereby established for subsequent
study.
3.2. Cell Viability, CCT2, and F/G-Actin Ratio in Groups
with and without Low CCT2 after Glucose Stimulation.
Using the ratio 6:2 of TR-to-siRNA for conducting CCT2
knockdown experiments, six groups, TR pN, CsiRNA pN,
CCT2siRNA pN, TR pH, CsiRNA pH, and CCT2siRNA pH,
were designed to test the cell viability and to verify the
eﬀect of CCT2siRNA. First, there were no diﬀerences among
six groups for cell viability (data not shown), suggesting
that the six groups had a similar outcome for cell viability.
Second, as for the expression of CCT2, as Figures 2(a1)
and 2(a2) show, mMCs from groups TR pH and CsiRNA
pH both had statistically higher expression than did counter
groups TR pN and CsiRNA pN. There were no diﬀerences
between TR pH and CsiRNA pHo rb e t w e e nT RpNa n d
CsiRNA pN, suggesting that scramble siRNA did not lead
to degradation of cellular CCT2. Groups CCT2siRNA pN
and CCT2siRNA pH showed a signiﬁcant attenuating eﬀect
when compared to those of other groups. We conﬁrmed
that, under the ratio of 6:2 between TR and amount of
siRNA, the expression of CCT2 decreased signiﬁcantly in
mMCs incubating in normal or high glucose, irrespectively.
As groups with and without scramble siRNA showed equal
eﬀect on the expression of CCT2, groups CsiRNA pN, CCT2
siRNA pN, CsiRNA pH, and CCT2 siRNA pH were chosen
for subsequent experiments.
Protein extracts from four groups, CsiRNA pN,
CCT2siRNA pN, CsiRNA pH, and CCT2siRNA pH, were
investigated for F/G-actin ratio. As Figures 2(b1) and
2(b2) show, the F/G-actin ratio in groups CCT2siRNA pN,
CsiRNA pH, and CCT2siRNA pH was statistically lower
than that of group CsiRNA pN. There was no diﬀerence4 Experimental Diabetes Research
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Figure 1: Optimal ratio between transfection reagent (TR) and
volume of siRNA (TR-to-siRNA) for a low CCT2 mouse mesangial
cell (mMC) model. The volume of TR was ﬁxed at 6ul, and
transfection was performed with varying volumes of CCT2 siRNA.
Representative plots show (a) western blotting used for the expres-
sion of CCT2 in mMC treated by TR only and TR plus CCT2siRNA
at the ratios of 6:2, 6:4, and 6:6 and (b) the normalized CCT2
expression against GAPDH for above groups, in which group 6:2
displays an ideal suppressive eﬀect on CCT2 and was chosen for
subsequent experiments. ∗P<0.05 versus group TR.
among those three groups, suggesting that high glucose and
CCT2siRNA both had a similar eﬀect on mMC attenuating
F/G-actin ratio. However, there was no synergetic eﬀect in
high glucose plus CCT2siRNA. In summary, our ﬁndings
suggest that H glucose and low CCT2 may decrease the
F/G-actin ratio in mMC.
3.3.ChangeofCellContraction,F/G-ActinRatio,andArrange-
ment of F-Actin in the Groups with and without Low CCT2
afterGlucoseStimulation. AsshowninFigures3(a)and3(b),
changes in the planar surface areas of mMCs in response
to 1μM PMA stimulation every 10min were observed for
groups CsiRNA pN, CCT2siRNA pN, CsiRNA pH, and
CCT2siRNA pH. Diﬀerences in the baseline planar areas of
these four groups were not statistically signiﬁcant before the
addition of PMA (data not shown). After PMA stimulation,
mMC planar areas of the group CsiRNA pN decreased to
40%–50% of their original areas. However, groups CsiRNA
pH, CCT2siRNA pN, and pH showed the smallest change
in planar surface area when compared to that of group
CsiRNApN,andnosigniﬁcantdiﬀerenceincontractilitywas
observed among these three groups. Our ﬁndings suggest
that mMCs treated by H glucose or CCT2siRNA both
showedasimilareﬀectontheattenuatingofPMA-stimulated
contraction, and there was no synergetic eﬀect for H glucose
plus CCT2siRNA.
Taking the results of the expression of CCT2, F/G-
actin ratio, and cell contraction together, groups with low
CCT2 had an associated low F/G-actin ratio before PMA
stimulation, and then these groups displayed signiﬁcantly
less cell contraction than that of normal F/G-actin ratio.
As for the expression of F/G-actin ratio and the arrange-
ment of F-actin in mMCs before and after PMA stimulation,
as Figure 3(c) shows, the change of F-actin distribution in
mMC had obviously redistributed from bundle to aggrega-
tion after PMA 60  stimulation. As Figure 3(d) shows, the
expressionofF/G-actinratioinallgroupsremainedasimilar
pattern before and after PMA stimulation.
In summary, our ﬁndings suggest that mMCs with low
CCT2 or treated by H glucose may decrease the F/G-actin
ratio and also show less cell contraction in PMA-induced cell
contractionandF-actinaggregationafterPMA,butmaintain
a similar F/G-actin ratio before and after PMA stimulation.
3.4. Change of Cell Proliferation, Migration, F/G-Actin Ratio,
and Arrangement of F-Actin in Groups with and without
Low CCT2 after Glucose Stimulation. For the change in
mesangial cell proliferation under treated conditions, the
data of MTT at time points 0 and 12hr from groups CsiRNA
pN, CCT2siRNA pN, CsiRNA pH, and CCT2siRNA pH
were analyzed. At the point of 0hr, group CsiRNA pH
showed a signiﬁcant increase over that of groups CsiRNA
pN, CCT2 siRNA pN, and pH, suggesting that H glucose
increased mMCs proliferation, but CCT2 siRNA blocked
this eﬀect (data not shown). Furthermore, as Figure 4(c)
shows, the rate of mMC proliferation between 0hr and 12hr
was calculated, and no signiﬁcant changes among these four
groups were found. Taken together, our ﬁndings suggest that
H glucose increases mMC proliferation, but CCT2 siRNA
reverses it.
For the observation of mMC migration, the percentage
of wound closure at the time points 0 and 12hr from groups
CsiRNA pN, CCT2 siRNA pN, CsiRNA pH, and CCT2siRNA
pH was analyzed. Group CsiRNA pH showed signiﬁcantly
enhanced ability of mMC migration when compared to
that of groups CsiRNA pN, CCT2siRNA pN, and pH
(Figures 4(a) and 4(b)). Among CsiRNA pN, CCT2siRNA
pN, and pH, there was no diﬀerence in the eﬀect on cell
migration, suggesting CCT2siRNA may have a reversing
eﬀect, particularly in mMCs incubating in H glucose.
As for the arrangement of F-actin and expression of the
F/G actin ratio in the process of mMC proliferation and
migration, the distribution of F-actin and F/G-actin ratio in
mMC at 0 and 12hr showed no signiﬁcant change (Figures
4(d) and 4(e)).
Taking the data of migration and proliferation together,
our ﬁndings suggest that H glucose activates mMC prolifera-
tion and enhances the ability of mMC migration, which canExperimental Diabetes Research 5
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Figure 2: CCT2 and F/G-actin ratios in the CCT2 cell model with and without high glucose induction. The TR-to-siRNA ratio of 6:2
was used for the CCT2 knockdown experiment with evaluation of F/G-actin ratio on six designated groups. Representative plots show (a1)
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Figure 4: Change of cell proliferation, migration, F/G-actin ratio, and arrangement of F-actin in CCT2 cell model with and without high
glucose stimulation. The same four designated groups in previous experiments were studied with high and normal glucose cultured for
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pH exhibited the highest migration activity among these groups. These experiments were performed in triplicate, and the rate of migration
activity was calculated as % = (area at 0hr–area at 12hr)/area at 0hr. Changes in actin were also studied. Representative pictures show (d)
the immunohistochemical blotting of actin with highlighting F-actin (green) and nuclei (blue) and (e) the change of F/G-actin ratio during
the migration testing interval. As seen, a similar pattern of no signiﬁcant change was observed across the four groups.8 Experimental Diabetes Research
be blocked by CCT2siRNA, but is not related to the change
of F-actin.
4. Discussion
In our study, a low CCT2 cell model was established, and
we found that the ideal ratio of TR-to-siRNA was 6:2 for
blocking CCT2 in mMC. Second, a novel ﬁnding was that
mMCs treated by H glucose or with low CCT2 showed
less cell contraction induced by PMA, which mechanism
involves decreasing F-actin. Third, H glucose activated mMC
proliferation and enhanced the ability of mMC migration,
which can be blocked by CCT2siRNA, but is not related
to the change of F-actin. In summary, CCT2 is a regulator
of mMC functions, which mechanisms may involve F-actin,
particularly for cell contraction.
A new low CCT2 mMC model is established by siRNA in
our study. The method of siRNA has been used to silence
gene expression for studying gene function in cultured
cells since 1998 [19]. However, the knockdown eﬃciency
is dependent on the cell line, culture condition, amount
of transfection reagent, siRNA quantity and quality, and
exposure time of transfection agent to cell. Determination of
thetransfectioneﬃciencyisrecommendedwhenusinganew
cell line. In our study, the ratio of 2:6 may not completely
block the function of CCT2, but it appears to be adequate for
downregulating CCT2 in mMC.
The relationship between CCT2 and kidney cells has
never been studied in the past; our ﬁndings ﬁrstly demon-
strate that CCT2 is a regulator of mMC functions aﬀected by
glucose. CCT is a mammalian cytosolic chaperonin required
for proper folding of proteins involved in cytoskeletal
formation and contractility activity [20–22]. CCT has eight
subunits, but the subunits of CCT diﬀer appreciably among
cell types [23], and the levels of diﬀerent CCT subunits may
have distinct expression in response to diﬀerent stresses [24,
25].Ofeightsubunits,CCT2wasassignedinthisstudybased
on our previous study [13]. We hypothesized that CCT2
would play a major role regulating mMC functions aﬀected
by glucose, also taking into account previous ﬁndings
that CCT2 is related to regulation of cell cycle, neuronal
diﬀerentiation, and stimulation of chemical stress [23]. The
novel ﬁnding of our study is that blocking CCT2 in mMC
may inhibit cell proliferation, migration, and contraction
induced by H glucose stress.
The relationship between CCT and cell cytoskeleton has
been proved by considerable evidence, but there has been
no study focusing on CCT or CCT2 and kidney cells. Actin
regulating cell movement and division [26] has been known
to fold by CCT for 20 years [23, 27–29]. Evidence suggests
that disruptions to actin dynamics can lead to changes
in cell morphology and cytoskeletal assembly [26, 30]. Of
CCT’s 8 subunits, individual CCT subunits play a role in
maintaining the normal function of actin [26]. Based on our
data, knockdown of the expression of CCT2 in mMCs can
lead to the signiﬁcant decrease of F-actin, resulting in the
alteration of cell contraction induced by PMA.
Accordingly, attenuating the expression of CCT2 by
siRNA in mMC has a similar eﬀe c ta st h a to fm M C st r e a t e d
by H glucose, showing a decrease in F/G actin ratio and
the lessening of PMA-induced cell contraction. It is known
that cell contraction is modulated by actin polymerization,
which involves a number of signal transduction pathways
[6]. In this regard, the relationship among H glucose, F-
actin, and mMC contraction may be rationalized as follows.
In 1998, Zhou et al. have suggested that high glucose alters
actin assembly in mesangial cell in vivo and in vitro,w h i c h
could account for lack of response to vasopressor agents
[31]. Our data was consistent with this observation in
mMC. Next, in terms of the relationship among CCT2, F-
actin, and mesangial cells, Brackley et al. demonstrated that
individual CCT plays a role in the expression of F-actin and
then inﬂuences cytoskeletal organization [32, 33]. Also, they
suggest that CCT monomers have a function independent
of the CCT oligomer to indicate that some CCT subunits
may carry some forms of chaperone activity. In our study,
the real role of CCT2 played by monomers or oligomers was
notinvestigated,butavailabledatastronglysuggestedthat,in
mMCs, attenuating the expression of CCT2 could lead to the
decrease of F/G actin ratio, subsequently lessening the PMA-
induced cell contraction. Furthermore, it was not observed
that H glucose plus CCT2 siRNA has a synergetic eﬀect
on decreasing cell contraction and F/G actin ratio. As the
observation is hard to prove with our data, our hypothesis
is that both factors may share the same pathway to inﬂuence
cell contraction.
In the study, another novel ﬁnding is that CCT2siRNA
lessens proliferation and migration in H glucose-induced
mMCs. In terms of CCT and cell proliferation, Grantham et
al. have demonstrated that siRNA-treated human cell lines
with a reduced CCT level show growth arrest [33], and the
degree of growth arrest highly correlates with the extent of
CCT depletion. However, which CCT subunits respond to
cell proliferation is not elucidated. In this regard, in our
study, the role of CCT2 in the proliferation of mMC was
established. On the other hand, regarding CCT and cell
migration, although Satish et al. suggest that downregu-
lating CCT6 blocks the migration of ﬁbroblast induced by
epidermal growth factor and platelet derived growth factor
[34], our ﬁndings show that downregulating CCT2 blocks H
glucose-induced mMC migration. Nevertheless, this ﬁnding
isdiﬀerentfromthatofSatishetal.,suggestingthechaperone
activity of individual CCT monomers is not conserved over
diﬀerent cell lines.
In conclusion, the reduction of CCT2 with siRNA signif-
icantly reduced the contraction, proliferation, and migration
of mMC, involving the alteration of F-actin, particularly in
contraction. CCT2 appears to have a signiﬁcant biological
eﬀect on the process of cellular motion.
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